Citigroup »

Aclaris Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $533k 508k 1.05
2023-09-30 $81k 12k 6.82
2023-03-31 $619k 77k 8.09
2022-12-31 $288k 18k 15.75
2022-09-30 $130k 8.3k 15.73
2021-12-31 $256k 18k 14.55
2021-03-31 $156k 6.2k 25.27
2020-12-31 $275k 43k 6.47
2020-03-31 $10k 9.8k 1.02
2019-12-31 $12k 6.2k 1.94
2019-09-30 $1.9k 2.1k 0.92
2019-06-30 $37k 17k 2.20
2019-03-31 $79k 13k 5.97
2018-12-31 $30k 4.0k 7.51
2018-09-30 $1.2k 121 9.90
2018-06-30 $999 61 16.39
2018-03-31 $2.0k 119 16.81
2017-12-31 $5.0k 200 25.00
2017-09-30 $2.0k 74 27.03
2017-06-30 $117k 4.3k 27.13
2017-03-31 $47k 1.6k 29.69
2016-12-31 $311k 12k 27.13
2016-09-30 $22k 854 25.76
2016-06-30 $18k 981 18.35
2015-12-31 $47k 1.7k 27.10